电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

MYC Induced Nuclear Antigen (MINA) (N-Term) Peptide

MINA 适用: 人 宿主: 合成 BP, WB
产品编号 ABIN980088
发货至: 中国

Quick Overview for MYC Induced Nuclear Antigen (MINA) (N-Term) Peptide (ABIN980088)

抗原

MINA (MYC Induced Nuclear Antigen (MINA))

宿主

资源

  • 5
合成

应用范围

Blocking Peptide (BP), Western Blotting (WB)
  • 蛋白结构域

    N-Term

    产品特性

    This is a synthetic peptide designed for use in combination with anti-MINA antibody (Catalog #: ARP30020_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    纯化方法

    Purified
  • 应用备注

    Each Investigator should determine their own optimal working dilution for specific applications.

    限制

    仅限研究用
  • 状态

    Lyophilized

    溶解方式

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    浓度

    1 mg/mL

    缓冲液

    Final peptide concentration is 1 mg/mL in PBS.

    注意事项

    Avoid repeated freeze-thaw cycles.

    储存条件

    -20 °C

    储存方法

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • 抗原

    MINA (MYC Induced Nuclear Antigen (MINA))

    背景

    MINA protein is directly involved in ribosome biogenesis, most likely during the assembly process of preribosomal particles. MINA is also involved in cell proliferation. MINA may have a role in esophageal squamous cell carcinoma, colon cancer and lung cancer.MINA is a c-Myc (MYC, MIM 190080) target gene that may play a role in cell proliferation or regulation of cell growth. (Tsuneoka et al., 2002 [PubMed 12091391], Zhang et al., 2005 [PubMed 15897898]).[supplied by OMIM].

    Alias Symbols: DKFZp762O1912, FLJ14393, MDIG, MINA53, NO52

    Protein Interaction Partner: MINA,MYC,MINA

    Protein Size: 465

    分子量

    53 kDa

    基因ID

    84864

    NCBI登录号

    NM_153182, NP_694822

    UniProt

    Q8IUF8
You are here:
Chat with us!